Company

Warp Sciences

AI and robotics-powered preclinical contract research organization (CRO) building robotic drug discovery labs in the US to reshore pharmaceutical R&D from China

RoboticsAIHealthcare & Biotech

People

Kevin Weilfounder

Funding History

Oct 22, 2026

Warp Sciences raised $215M led by Lightspeed Venture Partners with participation from IVP, Mayfield, Lux Capital, Menlo Ventures, Scribble Ventures, and angels including Fidji Simo, Brian Armstrong, Mark Chen, and Sarah Fryer. The company is building AI-powered robotic preclinical CRO labs in the US to reshore pharmaceutical research from China.

215M

Investors

IVPMayfieldLux CapitalMenlo VenturesScribble VenturesLightspeed Venture Partners

News

Interviews (3)

Kevin Weil raises $215M to build robotic drug discovery labs in America and reshore pharma R&D from China
22 Oct 2026
OpenAI CPO Kevin Weil on AI solving open math problems and launching Prism to accelerate science
29 Jan 2026
OpenAI CPO Kevin Weil on Codex, GPT-5, sycophancy postmortem, and why personalization is the next frontier
16 May 2025